Efficacy and safety of anticoagulation in atrial fibrillation patients with intracranial hemorrhage: A systematic review and meta-analysis

Efficacy and safety of anticoagulation in atrial fibrillation patients with intracranial hemorrhage: A systematic review and meta-analysis

Background: The benefits and risks of starting anticoagulation therapy, such as direct oral anticoagulations (DOACs) or warfarin, in atrial fibrillation (AF) patients with a history of intracranial hemorrhage (ICH) remain controversial. We performed a systematic review and meta-analysis to compare t...

Full description

Bibliographic Details
Main Authors:	Qiang Zhou, Xiang Liu, Xian Yang, Xiao-Hui Huang, Yan-Zi Wu, Ying-Ying Tao, Meng Wei
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-03-01
Series:	Frontiers in Pharmacology
Subjects:	atrial fibrillation intracranial hemorrhage oral anticoagulant therapy meta-analysis non-vitamin K antagonist oral anticoagulants
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1122564/full

Similar Items

Anticoagulation therapy in atrial fibrillation after intracranial hemorrhage
by: A. S. Gerasimenko, et al.
Published: (2021-05-01)

Intracranial hemorrhage in patients taking oral anticoagulants. Current possibilities for therapy
by: S. N. Yanishevsky
Published: (2019-06-01)

Trends in the Prescription of Non-Vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation: Results of the Polish Atrial Fibrillation (POL-AF) Registry
by: Iwona Gorczyca, et al.
Published: (2020-11-01)

Anticoagulation Holiday: Resumption of Direct Oral Anticoagulants for Atrial Fibrillation in Patients with Index Traumatic Intracranial Hemorrhage
by: Yohannes Ghenbot, et al.
Published: (2023-01-01)

Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study
by: Gilda Denise Zielinski, et al.
Published: (2020-01-01)

Why Did All Patients with Atrial Fibrillation and High Risk of Stroke Not Receive Oral Anticoagulants? Results of the Polish Atrial Fibrillation (POL-AF) Registry
by: Anna Szpotowicz, et al.
Published: (2021-10-01)

Novel oral anticoagulants in primary care in patients with atrial fibrillation: a cross-sectional comparison before and after their introduction
by: Simon Schwill, et al.
Published: (2018-07-01)

Major Hemorrhage Risk Associated with Direct Oral Anticoagulants in Non-Valvular Atrial Fibrillation: A Systematic Review and Meta-Analysis
by: Paraschos Archontakis-Barakakis, et al.
Published: (2022-10-01)

PRACTICAL CONCERNS OF ANTICOAGULATION IN NONVALVULAR ATRIAL FIBRILLATION: A UNIVERSITY CLINICS REGISTRY
by: A. A. Sokolova, et al.
Published: (2015-09-01)

Persistence with Anticoagulation for Atrial Fibrillation: Report from the GLORIA-AF Phase III 1-Year Follow-up
by: Monika Kozieł, et al.
Published: (2020-06-01)

2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation
by: Chern-En Chiang, MD, PhD, et al.
Published: (2017-08-01)

Global Oral Anticoagulation Use Varies by Region in Patients With Recent Diagnosis of Atrial Fibrillation: The GLORIA‐AF Phase III Registry
by: Valentina Bayer, et al.
Published: (2022-03-01)

Quality of vitamin K antagonist oral anticoagulation in 322 patients with atrial fibrillation – real-life data from a survey in Eastern Switzerland
by: Micha T. Maeder, et al.
Published: (2017-10-01)

Current Use of Oral Anticoagulation Therapy in Elderly Patients with Atrial Fibrillation: Results from an Italian Multicenter Prospective Study—The ISNEP Study
by: Francesco De Stefano, et al.
Published: (2022-08-01)

Use of non-vitamin K antagonists oral anticoagulants in atrial fibrillation patients on dialysis
by: Wenhao Li, et al.
Published: (2022-09-01)

Oral anticoagulation – current knowlegde
by: Anna Karaś, et al.
Published: (2022-10-01)

Atrial Fibrillation and Stroke. A Review on the Use of Vitamin K Antagonists and Novel Oral Anticoagulants
by: Alfredo Caturano, et al.
Published: (2019-09-01)

Challenges of Anticoagulant Therapy in Atrial Fibrillation—Focus on Gastrointestinal Bleeding
by: Alina Scridon, et al.
Published: (2023-04-01)

Anticoagulation therapy in the elderly with non-valvular atrial fibrillation: a double-edged sword
by: Francesco Vetta, et al.
Published: (2017-07-01)

Non-Vitamin K Oral Anticoagulants Assessment in High Risk of Bleeding Patients with Non-Valvular Atrial Fibrillation
by: Pedro Silva Cunha, et al.
Published: (2022-02-01)

Oral Anticoagulants Preference in Hospitalized Patients with Acute Deep Vein Thrombosis or Non-Valvular Atrial Fibrillation
by: Ştefan Cristian Vesa, et al.
Published: (2020-10-01)

Optimal Anticoagulant Strategy for Periprocedural Management of Atrial Fibrillation Ablation: A Systematic Review and Network Meta-Analysis
by: Tabito Kino, et al.
Published: (2022-03-01)

The efficacy and safety of direct oral anticoagulants compared with vitamin K antagonist in patients with hypertrophic cardiomyopathy and atrial fibrillation
by: Si-qi Lyu, et al.
Published: (2024-01-01)

Early Anticoagulation in Patients with Acute Ischemic Stroke Due to Atrial Fibrillation: A Systematic Review and Meta-Analysis
by: Lina Palaiodimou, et al.
Published: (2022-08-01)

Aneurysmal Subarachnoid Hemorrhage in Hospitalized Patients on Anticoagulants—A Two Center Matched Case-Control Study
by: Michael Veldeman, et al.
Published: (2023-02-01)

Anticoagulation in Atrial Fibrillation Cardioversion: What Is Crucial to Take into Account
by: Fabiana Lucà, et al.
Published: (2021-07-01)

Once- or twice-daily non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation: A meta-analysis of randomized controlled trials
by: Kang-Ling Wang, et al.
Published: (2017-08-01)

Contemporary trends and barriers to oral anticoagulation therapy in Non-valvular atrial fibrillation during DOAC predominant era
by: Ojasav Sehrawat, et al.
Published: (2023-06-01)

Adaptation of New Oral Anticoagulants for Warfarin Anticoagulated Patient with Traumatic Ongoing Hemorrhage
by: Jin Bong Ye, et al.
Published: (2018-04-01)

Impact of baseline renal function on the efficacy and safety of different Anticoagulants in Atrial Fibrillation Patients – A cohort study
by: Wei-Chieh Lee, et al.
Published: (2022-10-01)

Clinical Outcomes in Patients With Atrial Fibrillation Treated With Non–Vitamin K Oral Anticoagulants Across Varying Body Mass Index
by: Astrid Fritz Hansson, et al.
Published: (2023-11-01)

Central American and Caribbean Consensus Document for the Optimal Management of Oral Anticoagulation in Patients with Non-Valvular Atrial Fibrillation Endorsed by the Central American and Caribbean Society of Arterial Hypertension and Cardiovascular Prevention
by: Fernando Wyss, et al.
Published: (2024-01-01)

A cross-sectional study of appropriateness evaluation of anticoagulation therapy for inpatients with nonvalvular atrial fibrillation
by: Xiao-Yuan Zheng, et al.
Published: (2023-12-01)

Stroke prevention for non-valvular atrial fibrillation: how to make the right choice of directly acting oral anticoagulants?
by: N. N. Kryukov, et al.
Published: (2019-02-01)

Running after Activated Clotting Time Values in Patients Receiving Direct Oral Anticoagulants: A Potentially Dangerous Race. Results from a Prospective Study in Atrial Fibrillation Catheter Ablation Procedures
by: Karim Benali, et al.
Published: (2021-09-01)

Prevention of thromboembolic complications in patients with atrial fibrillation and obesity
by: Izabela Kolasa, et al.
Published: (2023-04-01)

Oral anticoagulant therapy for older patients with atrial fibrillation
by: Mario Bo, et al.
Published: (2017-09-01)

ATRIAL FIBRILLATION IN PATIENTS WITH HEMORRHAGIC STROKE: APPROACHES TO ANTICOAGULANT THERAPY
by: A. M. Kulagina, et al.
Published: (2017-05-01)

Pattern of oral anticoagulant prescribing for atrial fibrillation in general practice: an observational study in The Netherlands
by: Catharina CM Kager, et al.
Published: (2023-03-01)

The Therapy with Oral Anticoagulants in Patients with Atrial Fibrillation in Outpatient and Hospital Settings (Data from RECVASA Registries)
by: M. M. Loukianov, et al.
Published: (2019-09-01)